[Remote] Associate Medical Director / Medical Director, Clinical Development at Tempus

Maryland, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Pharmaceuticals, Medical ResearchIndustries

Skills

Key technologies and capabilities for this role

Genomic assaysAlgorithmic diagnosticsClinical validationClinical utility studiesData analysisStudy designMultidisciplinary collaborationScientific communicationRegulatory knowledgeOncology expertise

Questions & Answers

Common questions about this position

What are the location requirements for this position?

The position will be based in the Tempus hub in Chicago, IL; New York, NY; or Redwood, CA.

What is the salary range for this role?

This information is not specified in the job description.

What are the key required qualifications and skills for this role?

Candidates must have an MD degree or equivalent with advanced training in Oncology preferred, 5 years of clinical research experience in biotechnology/pharmaceutical, CRO, or academic settings, strong analytical and strategic thinking, communication skills, and the ability to lead cross-functional teams.

What is the work environment like at Tempus for this role?

The role involves working collaboratively in multidisciplinary matrix teams in a fast-paced environment, leading cross-functional teams including biostatistics, R&D, bioinformatics, and others.

What makes a strong candidate for this Medical Director position?

Strong candidates will have an MD with oncology training, 5+ years in clinical research, experience leading teams and engaging sites, plus preferred knowledge in genomics, AI, or real-world evidence, along with innovative thinking and adaptability in fast-paced settings.

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free